溃疡性结肠炎（UC）作为一种慢性炎症性肠病，具有患病率高、反复发作、长期预后差的特点。相关研究表明，96%的UC患者社会活动会受疾病影响，疾病10年进展率达67.5%，且17.1%的患者在确诊20年内可能发展为结直肠癌，既给患者带来沉重健康负担，也加剧了医疗系统压力。刚刚，2026年2月6日，云顶新耀官网宣布，中国国家药品监督管理局(NMPA)已批准精氨酸艾曲莫德片上市，用于治疗对传统治疗或...
Source Link溃疡性结肠炎（UC）作为一种慢性炎症性肠病，具有患病率高、反复发作、长期预后差的特点。相关研究表明，96%的UC患者社会活动会受疾病影响，疾病10年进展率达67.5%，且17.1%的患者在确诊20年内可能发展为结直肠癌，既给患者带来沉重健康负担，也加剧了医疗系统压力。刚刚，2026年2月6日，云顶新耀官网宣布，中国国家药品监督管理局(NMPA)已批准精氨酸艾曲莫德片上市，用于治疗对传统治疗或...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.